Date de publication: 2 décembre 2013
Promoteur – Intermédiaire Financier
HollandPTC B.V.Lieu
Description
New research-focused proton therapy (PT) centre in Western Holland promoted by Delft University of Technology, Leiden University Medical Centre and Erasmus University Medical Centre Rotterdam.
Objectifs
The project consists of the construction and development of a new proton therapy research centre jointly promoted by three leading universities in the Netherlands: Erasmus University Medical Centre Rotterdam, Leiden University Medical Centre and Delft University of Technology. Their joint-venture for this project is named Holland PTC and aims at assessing the efficacy of proton technology by conducting basic and clinical research. At least 600 cancer patients will be included annually in clinical studies. The centre is expected to be built in the Delft University of Technology’s science park and be functional from 2016 onwards. EIB will be involved in the financing of both the centre and the research and development (R&D) investment programme which will be carried out at HollandPTC.
Secteur(s)
Montant BEI envisagé (montant approximatif)
EUR 90 million
Coût total (montant approximatif)
EUR 120 million
Aspects environnementaux
The Nuclear Energy Permit, including Environmental Impact section, has been granted to Technische Universiteit Delft (TUD) for the Holland Particle Centre BV.
Passation des marchés
The Bank will require the promoter to ensure that contracts for the implementation of the project shall be awarded in conformity with EU Public Procurement Directive 2004/18/EC.
Statut
Signé - 9/05/2014
Clause de non-responsabilité
Avant d’être approuvés par le Conseil d’administration et avant la signature des prêts correspondants, les projets font l’objet d’une instruction et de négociations. Par conséquent, les informations et données fournies sur cette page sont indicatives.
Elles sont fournies à des fins de transparence uniquement et ne peuvent être considérées comme représentant la politique officielle de la BEI (voir également les notes explicatives).